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ABSTRACT
Nasopharyngeal carcinoma (NPC) is a carcinoma that arises from the 
nasopharyngeal mucosa and differs from other head and neck carcinomas 
by its unique histologic, epidemiologic, and biologic characteristics. NPC 
is rare in most countries, especially Europe and North America. However, 
it has a high incidence in several regions of South China. The incidence 
variability of NPC, among different geographical and ethnic groups, indicates 
a combination of genetic susceptibility, infection by Epstein-Barr virus and 
environmental factors. NPC is classified into three histological subtypes 
according to the 1991 World Health Organization classification: squamous 
cell carcinoma, nonkeratinizing carcinoma, and basaloid squamous cell 
carcinoma. The symptoms of patients with NPC are related to the primary 
tumor site and the degree of dissemination. Therefore, patients can remain 
asymptomatic during a long period of time. Imaging exams and biopsy of the 
tumor mass generally are sufficient to establish the diagnosis. NPC is a rare 
disease among children. The authors report a case of a 12-year-old boy who 
sought medical attention complaining of a progressive growing tumoral mass 
on the right side of the neck. The computed tomography images of the head 
and neck and the histological examination of a cervical lymph node biopsy 
diagnosed a metastatic NPC.
Keywords: Nasopharyngeal carcinoma; Lymph node excision; Tomography, x-ray computed; 
Immunohistochemistry.
CASE REPORT
A 12-year-old male patient, previously 
healthy, sought medical attention complaining of 
a progressive growing tumoral mass on the right 
side of the neck, during the last month. The patient 
referred fever and oral bleeding since the beginning 
of the symptoms. He denied weight loss and night 
sweats. His primary care physician prescribed 
antibiotics, without any improvement.
On physical examination, three painless 
enlarged lymph nodes were present on the anterior 
and posterior, right cervical chain, and on the 
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hepatitis B virus, hepatitis C virus, hepatitis A virus, 
HIV, and syphilis were all negative. Serology for 
Epstein-Barr virus (EBV) was IgG positive and IgM 
negative.
An incisional biopsy was performed, and 
multiple, irregular fragments were removed, 
measuring 2.0 × 1.0 × 0.4 cm. All samples were 
submitted to histopathological evaluation, which 
revealed marked fibrosis and reactive lymphoid 
tissue with expanded paracortical zones. Focal 
areas of micro abscesses and cohesive groups 
of atypical cells with monotonous vesicular 
nuclei, prominent nucleoli, and lightly eosinophilic 
anterior left cervical chain, measuring up to 5.0 
cm. On palpation, all nodules were hard, fixed to 
surrounding tissues, without fluctuation points, 
and showed well-defined limits. The rest of the 
physical examination was unremarkable. Computed 
tomography (CT) of the neck revealed multiple, 
bilateral nodular masses images, some coalescent, 
on the pharyngeal, submandibular regions, and 
along the carotid arteries, measuring up to 4.0 cm. 
Facial and abdominal CT were normal (Figures 1 
and 2).
Laboratory workup was normal, and serology 
for toxoplasmosis (IgG and IgM), cytomegalovirus, 
Figure 2 – Axial computed tomography of the head and neck. A - (Bone window) hypodense material fulfilling 
the mastoid cells (white arrow) and the middle ear (black arrow), compatible with ostomastoiditis; B - After 
intravenous injection of the contrast, rhinopharyngeal infiltrative tumoral mass (black arrows), larger on the 
right side, obliterating Rosenmüller’s fossa.
Figure 1 – Multidetector computed tomography of the head and neck. Coronal reformatted images 
after intravenous contrast injection. A - Infiltrating rhinopharyngeal masses spreading to the retro and 
parapharyngeal spaces; B - Multiple confluent lymph nodes with cystic/necrotic central areas scattered in 
various cervical plans, bilaterally.
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Given the histological, clinical, and 
tomographic findings, diagnosis was concluded 
as lymph node metastatic undifferentiated 
nonkeratinizing nasopharyngeal carcinoma (NPC).
DISCUSSION
We report a case of a 12-year-old boy 
with a cervical mass that revealed a metastatic 
NPC after histopathological examination. NPC is 
cytoplasm with indistinct cell borders, resulting in 
a syncytial appearance were present (Figure 3). 
The immunohistochemical study is summarized in 
Table 1 and Figure 4.
The histological findings combined with the 
immunohistochemical results were consistent with 
metastatic lymphoepithelial carcinoma. Based on 
histological diagnosis, endoscopic exam of the 
nasopharyngeal cavity was undertaken, resulting in 
a disclosure of a suspicious mass localized on the 
nasopharynx, confirmed by CT images (Figure 5).
Table 1 – Immunohistochemical panel used for diagnosis
Antigen Clone Dilution Manufacturer Result
AE1–AE3 AE1–AE3 1:2000 Cell Marque Positive on atypical cells
EBV CS1/CS2/CS3/CS4 1:2000 DAKO Positive on atypical cells
CD20 L26 1:6000 DAKO Negative (positive on B lymphocytes)
CD3 policlonal 1:1500 DAKO Negative (positive on T lymphocytes)
CD68 PG-M1 1:5000 DAKO Negative (positive on B histiocytes)
CD30 Ber – H2 1:400 DAKO Negative (positive on focal reactive lymphocytes)
CD21 2G9 1:1200 Novocastra Negative (positive on dendritic cells)
CD138 MI15 1:1200 DAKO Negative (positive on plasmocytes
Figure 3 – A - Fibrosis and reactive lymphoid tissue; B - Islands of atypical cells with syncytial appearance; 
C and D - Atypical cells showing monotonous vesicular nuclei with prominent nucleoli, and lightly eosinophilic 
cytoplasm with indistinct cell borders (H&E).
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NPC is rare in most countries, especially in 
Europe and North America. In the United States, it 
accounts for 0.25% of all malignancies.2 However, 
it has a high incidence in several areas of Southern 
China,3 where the incidence ranges from 15% 
to 18% of all malignancies. It also accounts for 
10-20% of childhood malignancies in Africa.2 Its 
incidence varies from less than 1 per 100,000 
person-years in low-incidence regions to more than 
20 per 100,000 person-years in endemic regions.4 
In high-risk groups, NPC incidence raises after the 
age of 30 years and peaks at 40-60 years, declining 
afterwards. Gender predominance is observed with 
the relation between men and women of 2-3/1.2,5 In 
general, populations that migrate from high to low 
risk areas retain much of the elevated risk seen in 
their country of origin.6
NPC is a rare disease among children.7 
Although great variability does exist concerning racial 
and geographical groups, this neoplasia constitutes 
from 1% to 5% of all cancers and from 20% to 50% 
of all primary nasopharyngeal malignant tumors in 
children.8-10 The mean age of NPC development is 
13 years, and incidence is highest among males 
(male to female ratio 1.8:1) and Black people.11,12
Figure 5 – Multidetector computed tomography of 
the head and neck. Sagittal reformatted images 
after intravenous contrast injection, showing an 
infiltrative mass in the rhinopharinx (arrow).
Figure 4 – Immunohistochemistry. A - AE1-AE3 positive on atypical cells; B - EBV (LMP1) positive on atypical 
cells; C - CD20 positive only on small lymphocytes B; D - CD3- positive only on the small T lymphocytes.
a carcinoma that arises from the nasopharyngeal 
mucosa and differs from other head and neck 
carcinomas by its unique histologic, epidemiologic, 
and biologic characteristics.1 It has as synonyms 
lymphoepithelioma, lymphoepithelioma-like 
carcinoma, and lymphoepithelial carcinoma.
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nuclei, and large central nucleoli characterize the 
undifferentiated subtype, which is more common. 
The lymph nodes can be involved extensively or 
subtly; the tumor takes the form of islands and 
strands, being intermingled with variable numbers 
of lymphocytes, plasma cells, and eosinophils. 
In cases of cervical lymph node metastases, the 
differential diagnoses are Hodgkin lymphoma, 
anaplastic lymphoma, and diffuse large B-cell 
lymphoma. The differentiated subtype differs from 
the undifferentiated subtype by showing cellular 
stratification often paved by a plexiform growth, 
reminiscent of transitional cell carcinoma of the 
bladder.19 The tumor cells show well-defined 
cell borders and sometimes-vague intercellular 
bridges; there also may be exceptionally occasional 
keratinized cells.20
Nonkeratinizing NPC is associated with EBV 
infection in virtually 100% of cases, irrespective of 
the ethnic background of the patient. By contrast, 
EBV latent membrane protein-1 (LMP1) is 
usually positive in only 30-40% of cases, and the 
immunostaining is often patchy and weak. The 
simplest and most reliable way to demonstrate EBV 
is in-situ hybridization for EBV-encoded early RNA. 
Practically all tumor cells show a strong reaction for 
pan-cytokeratin (AE1/AE3, MNF-116).20 The case 
reported here, showed an immunohistochemistry 
expression of AE1/AE3 and EBV on atypical cells, 
and a negative reaction for other lymphoid markers, 
leading to the diagnosis of NPC.
NPC often originates from the pharyngeal 
recess, the Rosenmüller’s fossa. The primary 
tumor may present as a smooth bulging mucosa, 
a discrete nodule with or without ulceration, or an 
infiltrating mass.21 In general, this tumor spread via 
nasopharyngeal mucosa and submucosa along 
adjacent muscle and adipose planes and into bone 
foramina. As in the case presented here, most 
patients present a disseminated disease on the first 
consultation.21,22
The symptoms of patients with NPC are 
related to the primary tumor site and its degree 
of dissemination. Because of the anatomical 
peculiarities of the nasopharynx and the insidious 
growth of the tumor in this area, the nasopharynx 
has been considered a “blind spot”, inaccessible to 
clinical evaluation. Therefore, patients can remain 
in a lengthy asymptomatic period.21,22 In children, 
the most common presenting symptom is a painless 
mass in the upper neck, which may be quite large 
at the first medical consultation. Local tumor effects 
The incidence variability of NPC between 
different geographical and ethnic groups indicates 
a combination of genetic susceptibility, infection by 
Epstein-Barr virus (EBV) and environmental factors 
(consumption of Chinese nitrosamine-rich salted 
fish and other salted food) in the pathogenesis of 
the disease.13 High antibody titers to EBV antigens 
(IgG and IgA) are useful diagnostic markers.2
A stepwise progression of histological 
features has been recently described. Patches of 
dysplasia are the earliest recognizable lesions, 
which are associated with allelic losses on the 
short arms of chromosomes 3 and 9, which result 
in inactivation of several tumor suppressor genes, 
particularly p14, p15, and p16. These dysplastic 
areas are the origin of the tumor, but are probably 
insufficient to lead its further progression. At this 
stage, latent EBV infection becomes critical and 
leads to the development of severe dysplasia. 
Gains of genes on chromosome 12 and allelic loss 
on 11q, 13q, and 16q result in invasive carcinoma. 
Metastases are associated with mutation of p53 
and aberrant expression of cadherins.14,15
NPC is divided into three histological 
subtypes in accordance with the World Health 
Organization (WHO) classification of 1978, which 
are: squamous cell carcinoma (WHO type I), 
nonkeratinizing carcinoma (WHO type II), and 
undifferentiated carcinoma (WHO type III).16 In 
the 1991 WHO classification, the squamous cell 
carcinoma subtype (keratinizing squamous cell 
carcinoma) was maintained. The last two subtypes 
of 1978 WHO classification were grouped in a single 
category of “nonkeratinizing carcinoma”, and were 
subdivided as “differentiated” or “undifferentiated”. 
The current WHO classification maintains the 
terminology of the 1991 classification, with the 
addition of a new category: basaloid squamous cell 
carcinoma.
Comparing keratinizing squamous cell 
carcinoma with nonkeratinizing carcinoma, a trend 
for locally advanced tumor growth in the former (76% 
vs 55%)17 as well as a lower incidence of lymph node 
metastasis (29% vs 70%).18 Keratinizing squamous 
cell carcinoma shows immunoreactivity for 
pancytokeratin, high molecular-weight cytokeratin, 
and focally epithelial membrane antigen.
The nonkeratinizing carcinoma can be 
subdivided in undifferentiated and differentiated 
subtypes. Syncytial-appearing large tumor cells 
with indistinct cell borders, round to oval vesicular 
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still used for radiotherapy planning, and in some 
centers, is used with positron emission tomography 
(PET) using 18F-FDG. PET/CT has been shown 
to be of value in NPC staging, detecting distant 
metastasis.2 In the case presented here, there was 
no evidence of the perineural dissemination on CT 
images. In this regard, magnetic resonance imaging 
(MRI) has shown greater diagnostic accuracy. MRI 
is an accurate test for detecting subclinical cancers 
missed at endoscopy and endoscopy biopsies, 
and is also useful for ruling out this diagnosis. 
The protocol for NPC includes unenhanced T1-
weighted images to detect skull base involvement 
and fat planes in at least an axial and sagittal 
plane. A T2-weighted fast spin-echo sequence in 
an axial plane is used for early parapharyngeal 
tumor spread, paranasal sinus invasion, middle ear 
effusions, and detection of cervical lymph nodes. 
Axial and coronal contrast-enhanced T1-weighted 
images (with or without fat suppression) are used 
to detect tumor extent, including perineural spread 
and intracranial extension of the tumor. Whole 
body MRI for metastatic deposits of NPC is not 
currently recommended.2 Lymph node involvement 
is suspected when node size exceeds 10 mm and 
when there is a peripheral ring enhancement by 
contrast medium and a central hypodensity.25
The treatment in children follows guidelines 
established for adults. The main treatment strategy 
for all cases of locoregional NPC has been high-
dose radiotherapy to the nasopharynx and involved 
lymph nodes of the neck, and a moderate dose 
of radiation to uninvolved nodes and surrounding 
tissue. By contrast, surgery is generally not feasible 
due to potentially inadequate margins of resection. 
Chemotherapy depends on metastatic or recurrent 
disease activity.12
Due to the low incidence of NPC in children, 
misdiagnosis or delayed diagnosis is frequent. 
Therefore, the disease has to be included in the 
differential diagnosis of lymph node enlargement 
since isolated lymph nodes metastasis to the neck, 
without clinical or radiological evidence of disease 
in the nasopharynx, may be observed.
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